Novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase

Bioorganic & Medicinal Chemistry Letters
2010.0

Abstract

A structure-based approach was pursued in designing novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase (hFPPS). Preliminary SAR and structural evidence for the simultaneous binding of these inhibitors into the isopentenyl pyrophosphate (IPP) and the geranyl pyrophosphate (GPP) substrate sub-pockets of the enzyme are presented.

Knowledge Graph

Similar Paper

Novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase
Bioorganic & Medicinal Chemistry Letters 2010.0
Design of potent bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase via targeted interactions with the active site ‘capping’ phenyls
Bioorganic & Medicinal Chemistry 2012.0
Thienopyrimidine Bisphosphonate (ThPBP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase: Optimization and Characterization of the Mode of Inhibition
Journal of Medicinal Chemistry 2013.0
Structure–Activity Relationships Among the Nitrogen Containing Bisphosphonates in Clinical Use and Other Analogues: Time-Dependent Inhibition of Human Farnesyl Pyrophosphate Synthase
Journal of Medicinal Chemistry 2008.0
Pyridinium-1-yl Bisphosphonates Are Potent Inhibitors of Farnesyl Diphosphate Synthase and Bone Resorption
Journal of Medicinal Chemistry 2005.0
Bisphosphonates target multiple sites in both cis - and trans -prenyltransferases
Proceedings of the National Academy of Sciences 2007.0
Design and Synthesis of Active Site Inhibitors of the Human Farnesyl Pyrophosphate Synthase: Apoptosis and Inhibition of ERK Phosphorylation in Multiple Myeloma Cells
Journal of Medicinal Chemistry 2012.0
Novel bisphosphonates with antiresorptive effect in bone mineralization and osteoclastogenesis
European Journal of Medicinal Chemistry 2018.0
Farnesyl Diphosphate Synthase Inhibitors With Unique Ligand-Binding Geometries
ACS Medicinal Chemistry Letters 2015.0
Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase
Bioorganic & Medicinal Chemistry Letters 2015.0